Industry: Medical Devices & Consumables
Published Date: 2026-04-17
Pages: 121 Pages
Report ld: 6021685
Request Sample
Customized Report
Insulin Safety Pen Needles Market Size(US$)

CAGR 2026-2032
9.2%
Market Size,2032
USD 501
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Insulin Safety Pen Needles market was valued at US$ 273 million in 2025 and is anticipated to reach US$ 501 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Insulin Safety Pen Needles competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Insulin safety pen needles are single-use, high-safety consumables engineered for insulin pens. Building on conventional pen needles, they integrate safeguards such as hidden tips, automatic retraction, dual locking, and anti-misfire features to reduce needlestick injuries and potential cross-contamination while enhancing puncture smoothness and injection comfort. The design prioritizes ergonomics, biocompatible materials, and manufacturing precision to upgrade safety across both self-administration and clinical settings. As patient education, infection control, and prescribing practices evolve, insulin safety pen needles have become a pivotal link in the insulin delivery value chain, aligning drug-device integration and compliance for home care, outpatient use, and chronic-disease follow-up scenarios.In 2024, global Insulin safety pen needles production reached approximately 635 million units, with an average global market price of around US$ 403.6 per k unit.
With chronic-disease management and infection control being reinforced, safety pen needles that feature protective structures and traceability align with extended prescribing practices and catalyze safety-centric product upgrades. Government standards and quality systems are tightening, while brokerage research highlights structural growth in premium consumables and annual reports from industry leaders emphasize compliance and brand moats—together advancing technology and standards on the supply side. In parallel, long-acting pipelines and diversified injection regimens from pharma create a platform for synergy between safety needles and intelligent delivery systems.Across varied reimbursement and procurement regimes, value realization faces constraints from cost sensitivity and differences in volume-based purchasing rules, calling for clearer evidence linking price to clinical benefit. Patent barriers, regulatory registration, and cross-regional quality harmonization raise entry thresholds, and supply chains face pressure in compliance, traceability, and continuity. Signals from annual reports and regulatory notices indicate stricter audits, making process validation, in-process control, and vigilance management sustained investment areas, with sector consolidation introducing transitional uncertainty.Growing patient self-management and education are shifting preferences toward products that blend safety, comfort, and convenience; standardized safety-injection protocols in primary care and specialty clinics support steady, batch-scale adoption. Digital follow-up and adherence management extend service elements into devices, driving ecosystem combinations of safety pen needles, smart pens, companion consumables, and data platforms. This enhances clinical visibility and compliance records and opens new dimensions for brand differentiation.Safety pen needles impose stringent requirements on medical-grade stainless steel, polypropylene and polycarbonate, elastomers, and silicone-based lubricants; material purity, micro-surface finishing, and lubricant stability directly influence puncture resistance and comfort. Updates reflected in annual reports and government standards elevate certification, traceability, and environmental compliance at the material level. High-quality suppliers gain leverage through robust systems and batch consistency, while leading manufacturers localize and diversify sourcing and use tooling plus automation upgrades to buffer yield from material volatility.
This report delivers a comprehensive overview of the global Insulin Safety Pen Needles market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Insulin Safety Pen Needles. The Insulin Safety Pen Needles market size, estimates, and forecasts are provided in terms of sales volume (M Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Insulin Safety Pen Needles market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Insulin Safety Pen Needles manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Insulin Safety Pen Needles manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Insulin Safety Pen Needles sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Insulin Safety Pen Needles Market Overview
1.1 Product Definition
1.2 Insulin Safety Pen Needles by Type
1.2.1 Global Insulin Safety Pen Needles Market Value by Type: 2025 vs 2032
1.2.2 Auto-Retractable Safety Pen Needles
1.2.3 Auto-Lock Safety Pen Needles
1.2.4 Manual Safety Pen Needles
1.3 Insulin Safety Pen Needles by Application
1.3.1 Global Insulin Safety Pen Needles Market Value by Application: 2025 vs 2032
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Online
1.4 Global Insulin Safety Pen Needles Market Size Estimates and Forecasts
1.4.1 Global Insulin Safety Pen Needles Revenue 2021–2032
1.4.2 Global Insulin Safety Pen Needles Sales 2021–2032
1.4.3 Global Insulin Safety Pen Needles Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Insulin Safety Pen Needles Market Competition by Manufacturers
2.1 Global Insulin Safety Pen Needles Sales Market Share by Manufacturers (2021–2026)
2.2 Global Insulin Safety Pen Needles Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Insulin Safety Pen Needles Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Insulin Safety Pen Needles, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Insulin Safety Pen Needles, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Insulin Safety Pen Needles, Product Types and Applications
2.7 Global Key Manufacturers of Insulin Safety Pen Needles, Date of Entry into the Industry
2.8 Global Insulin Safety Pen Needles Market Competitive Situation and Trends
2.8.1 Global Insulin Safety Pen Needles Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Insulin Safety Pen Needles Players Market Share by Revenue
2.8.3 Global Insulin Safety Pen Needles Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Insulin Safety Pen Needles Market Scenario by Region
3.1 Global Insulin Safety Pen Needles Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Insulin Safety Pen Needles Sales by Region: 2021–2032
3.2.1 Global Insulin Safety Pen Needles Sales by Region: 2021–2026
3.2.2 Global Insulin Safety Pen Needles Sales by Region: 2027–2032
3.3 Global Insulin Safety Pen Needles Revenue by Region: 2021–2032
3.3.1 Global Insulin Safety Pen Needles Revenue by Region: 2021–2026
3.3.2 Global Insulin Safety Pen Needles Revenue by Region: 2027–2032
3.4 North America Insulin Safety Pen Needles Market Facts & Figures by Country
3.4.1 North America Insulin Safety Pen Needles Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Insulin Safety Pen Needles Sales by Country (2021–2032)
3.4.3 North America Insulin Safety Pen Needles Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Insulin Safety Pen Needles Market Facts & Figures by Country
3.5.1 Europe Insulin Safety Pen Needles Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Insulin Safety Pen Needles Sales by Country (2021–2032)
3.5.3 Europe Insulin Safety Pen Needles Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Safety Pen Needles Market Facts & Figures by Region
3.6.1 Asia Pacific Insulin Safety Pen Needles Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Insulin Safety Pen Needles Sales by Region (2021–2032)
3.6.3 Asia Pacific Insulin Safety Pen Needles Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Insulin Safety Pen Needles Market Facts & Figures by Country
3.7.1 Latin America Insulin Safety Pen Needles Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Insulin Safety Pen Needles Sales by Country (2021–2032)
3.7.3 Latin America Insulin Safety Pen Needles Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Safety Pen Needles Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Safety Pen Needles Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Insulin Safety Pen Needles Sales by Country (2021–2032)
3.8.3 Middle East and Africa Insulin Safety Pen Needles Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Insulin Safety Pen Needles Sales by Type (2021–2032)
4.1.1 Global Insulin Safety Pen Needles Sales by Type (2021–2026)
4.1.2 Global Insulin Safety Pen Needles Sales by Type (2027–2032)
4.1.3 Global Insulin Safety Pen Needles Sales Market Share by Type (2021–2032)
4.2 Global Insulin Safety Pen Needles Revenue by Type (2021–2032)
4.2.1 Global Insulin Safety Pen Needles Revenue by Type (2021–2026)
4.2.2 Global Insulin Safety Pen Needles Revenue by Type (2027–2032)
4.2.3 Global Insulin Safety Pen Needles Revenue Market Share by Type (2021–2032)
4.3 Global Insulin Safety Pen Needles Price by Type (2021–2032)
5 Segment by Application
5.1 Global Insulin Safety Pen Needles Sales by Application (2021–2032)
5.1.1 Global Insulin Safety Pen Needles Sales by Application (2021–2026)
5.1.2 Global Insulin Safety Pen Needles Sales by Application (2027–2032)
5.1.3 Global Insulin Safety Pen Needles Sales Market Share by Application (2021–2032)
5.2 Global Insulin Safety Pen Needles Revenue by Application (2021–2032)
5.2.1 Global Insulin Safety Pen Needles Revenue by Application (2021–2026)
5.2.2 Global Insulin Safety Pen Needles Revenue by Application (2027–2032)
5.2.3 Global Insulin Safety Pen Needles Revenue Market Share by Application (2021–2032)
5.3 Global Insulin Safety Pen Needles Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Embecta
6.1.1 Embecta Company Information
6.1.2 Embecta Description and Business Overview
6.1.3 Embecta Insulin Safety Pen Needles Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Embecta Insulin Safety Pen Needles Product Portfolio
6.1.5 Embecta Recent Developments/Updates
6.2 MTD Group
6.2.1 MTD Group Company Information
6.2.2 MTD Group Description and Business Overview
6.2.3 MTD Group Insulin Safety Pen Needles Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 MTD Group Insulin Safety Pen Needles Product Portfolio
6.2.5 MTD Group Recent Developments/Updates
6.3 Novo Nordisk
6.3.1 Novo Nordisk Company Information
6.3.2 Novo Nordisk Description and Business Overview
6.3.3 Novo Nordisk Insulin Safety Pen Needles Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Novo Nordisk Insulin Safety Pen Needles Product Portfolio
6.3.5 Novo Nordisk Recent Developments/Updates
6.4 B. Braun
6.4.1 B. Braun Company Information
6.4.2 B. Braun Description and Business Overview
6.4.3 B. Braun Insulin Safety Pen Needles Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 B. Braun Insulin Safety Pen Needles Product Portfolio
6.4.5 B. Braun Recent Developments/Updates
6.5 Terumo
6.5.1 Terumo Company Information
6.5.2 Terumo Description and Business Overview
6.5.3 Terumo Insulin Safety Pen Needles Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Terumo Insulin Safety Pen Needles Product Portfolio
6.5.5 Terumo Recent Developments/Updates
6.6 Owen Mumford
6.6.1 Owen Mumford Company Information
6.6.2 Owen Mumford Description and Business Overview
6.6.3 Owen Mumford Insulin Safety Pen Needles Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Owen Mumford Insulin Safety Pen Needles Product Portfolio
6.6.5 Owen Mumford Recent Developments/Updates
6.7 Bepu Medical
6.7.1 Bepu Medical Company Information
6.7.2 Bepu Medical Description and Business Overview
6.7.3 Bepu Medical Insulin Safety Pen Needles Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Bepu Medical Insulin Safety Pen Needles Product Portfolio
6.7.5 Bepu Medical Recent Developments/Updates
6.8 Ulticare
6.8.1 Ulticare Company Information
6.8.2 Ulticare Description and Business Overview
6.8.3 Ulticare Insulin Safety Pen Needles Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Ulticare Insulin Safety Pen Needles Product Portfolio
6.8.5 Ulticare Recent Developments/Updates
6.9 Promisemed
6.9.1 Promisemed Company Information
6.9.2 Promisemed Description and Business Overview
6.9.3 Promisemed Insulin Safety Pen Needles Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Promisemed Insulin Safety Pen Needles Product Portfolio
6.9.5 Promisemed Recent Developments/Updates
6.10 Tianjin Huahong
6.10.1 Tianjin Huahong Company Information
6.10.2 Tianjin Huahong Description and Business Overview
6.10.3 Tianjin Huahong Insulin Safety Pen Needles Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Tianjin Huahong Insulin Safety Pen Needles Product Portfolio
6.10.5 Tianjin Huahong Recent Developments/Updates
6.11 Suzhou Shali Medical
6.11.1 Suzhou Shali Medical Company Information
6.11.2 Suzhou Shali Medical Description and Business Overview
6.11.3 Suzhou Shali Medical Insulin Safety Pen Needles Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Suzhou Shali Medical Insulin Safety Pen Needles Product Portfolio
6.11.5 Suzhou Shali Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Safety Pen Needles Industry Chain Analysis
7.2 Insulin Safety Pen Needles Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Safety Pen Needles Production Mode & Process Analysis
7.4 Insulin Safety Pen Needles Sales and Marketing
7.4.1 Insulin Safety Pen Needles Sales Channels
7.4.2 Insulin Safety Pen Needles Distributors
7.5 Insulin Safety Pen Needles Customer Analysis
8 Insulin Safety Pen Needles Market Dynamics
8.1 Insulin Safety Pen Needles Industry Trends
8.2 Insulin Safety Pen Needles Market Drivers
8.3 Insulin Safety Pen Needles Market Challenges
8.4 Insulin Safety Pen Needles Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Insulin Safety Pen Needles market size was US$ 273 million in 2025 and is forecast to reach a readjusted size of US$ 501 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 92
USD 4250.00
(Single User License)
The global market for Insulin Safety Pen Needles was estimated to be worth US$ 273 million in 2025 and is projected to reach US$ 501 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 130
USD 3950.00
(Single User License)
The global Insulin Safety Pen Needles market is projected to grow from US$ 256 million in 2024 to US$ 463 million by 2031, at a CAGR of 9.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 154
USD 4900.00
(Single User License)
The global Insulin Safety Pen Needles market size was US$ 256 million in 2024 and is forecast to a readjusted size of US$ 463 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 92
USD 4250.00
(Single User License)
The global market for Insulin Safety Pen Needles was estimated to be worth US$ 256 million in 2024 and is forecast to a readjusted size of US$ 463 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published Date: 2025-09-08
Pages: 128
USD 3950.00
(Single User License)
The global market for Insulin Safety Pen Needles was valued at US$ 256 million in the year 2024 and is projected to reach a revised size of US$ 463 million by 2031, growing at a CAGR of 9.2% during the forecast period.
Published Date: 2025-09-08
Pages: 93
USD 2900.00
(Single User License)
The global market for Insulin Safety Pen Needles was estimated to be worth US$ 5960 million in 2024 and is forecast to a readjusted size of US$ 8183 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 176
USD 3950.00
(Single User License)
Safety Pen Needles are sterile, single use needles intended for use with pen injector devices for the injection of drugs. Safety pen needles are intended for professional health care users and non-clinical pen users.
Published Date: 2024-01-14
Pages: 107
USD 2900.00
(Single User License)
The global Insulin Safety Pen Needles market size was US$ 273 million in 2025 and is forecast to reach a readjusted size of US$ 501 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 92
The global market for Insulin Safety Pen Needles was estimated to be worth US$ 273 million in 2025 and is projected to reach US$ 501 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-03-06
Pages: 130
The global Insulin Safety Pen Needles market is projected to grow from US$ 256 million in 2024 to US$ 463 million by 2031, at a CAGR of 9.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 154
The global Insulin Safety Pen Needles market size was US$ 256 million in 2024 and is forecast to a readjusted size of US$ 463 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 92
The global market for Insulin Safety Pen Needles was estimated to be worth US$ 256 million in 2024 and is forecast to a readjusted size of US$ 463 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published: 2025-09-08
Pages: 128
The global market for Insulin Safety Pen Needles was valued at US$ 256 million in the year 2024 and is projected to reach a revised size of US$ 463 million by 2031, growing at a CAGR of 9.2% during the forecast period.
Published: 2025-09-08
Pages: 93
The global market for Insulin Safety Pen Needles was estimated to be worth US$ 5960 million in 2024 and is forecast to a readjusted size of US$ 8183 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 176
Safety Pen Needles are sterile, single use needles intended for use with pen injector devices for the injection of drugs. Safety pen needles are intended for professional health care users and non-clinical pen users.
Published: 2024-01-14
Pages: 107
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now